About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Procedure for reviewingReviewers 2023-2024
Logout
Obstetrics and Gynegology2021№7
Modern methods of infertility treatment...

Modern methods of infertility treatment in patients with polycystic ovary syndrome

DOI
https://dx.doi.org/10.18565/aig.2021.7.37-44

Mikhailova N.D., Mishieva N.G., Kirillova A.O., Dzhincharadze L.G.

Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia
Polycystic ovary syndrome (PCOS) is one of the most common diseases in reproductive-aged women. This is a complex disease that affects various areas of a woman’s life and causes different problems, such as metabolic, reproductive, aesthetic, psychological, and sexual ones, and can seriously worsen a woman’s quality of life. PCOS is known to negatively affect female fertility and is the leading factor of infertility of endocrine origin. To achieve pregnancy in this patient category, there are various treatments, both medical and surgical ones, which are aimed at restoring folliculogenesis and inducing ovulation, and, if these methods are ineffective, assisted reproductive technologies are also used. But numerous studies indicate that the efficiency of infertility treatment in PCOS is not always high and depends on the clinical situation. Therefore, research is currently underway to determine the optimal methods of infertility therapy for patients of this group.
Conclusion. The presented literature review shows the experience with and efficiency of various methods of infertility treatment in patients with PCOS.

Keywords

infertility
PCOS
ovulation induction
gynecology
ART
IVF
Full text (in Russian)

References

  1. Ding T., Hardiman P.J., Petersen I., Wang F.F., Qu F., Baio G. The prevalence of polycystic ovary syndrome in reproductive-aged women of different ethnicity: a systematic review and meta-analysis. Oncotarget. 2017; 56(8): 96351-8. https://dx.doi.org/10.18632/oncotarget.19180.
  2. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil. Steril. 2004; 81(1): 19-25. https://dx.doi.org/10.1016/j.fertnstert.2003.10.004.
  3. Aversa A., La Vignera S., Rago R., Gambineri A., Nappi R.E., Calogero A.E. et al. Fundamental concepts and novel aspects of polycystic ovarian syndrome: Expert consensus resolutions. Front. Endocrinol. 2020; 11: 516. https://dx.doi.org/10.3389/fendo.2020.00516.
  4. Toosy S., Sodi R., Pappachan J.M. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. J. Diabetes Metab. Disord. 2018; 17(2):277-85. https://dx.doi.org/10.1007/s40200-018-0371-5.
  5. Cooney L.G., Lee I., Sammel M.D., Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis. Hum. Reprod. 2017; 32(5): 1075-91. https://dx.doi.org/10.1093/humrep/dex044.
  6. Basirat Z., Faramarzi M., Esmaelzadeh S., Abedi Firoozjai S.H., Mahouti T., Geraili Z. Stress, depression, sexual function, and alexithymia in infertile females with and without polycystic ovary syndrome: a case-control study. Int. J. Fertil. Steril. 2019; 13(3): 203-8. https://dx.doi.org/10.1093/humrep/dex044.
  7. Назаренко Т.А. Синдром поликистозных яичников: современные подходы к диагностике и лечению бесплодия. М.: МЕДпресс-информ; 2005. 208 с. [Nazarenko T.A. Polycystic ovarian syndrome: modern approaches to the diagnosis and treatment of infertility. M.: MEDPress-inform; 2005. 208 p. (in Russian)].
  8. Shelly W., Draper M.W., Krishnan V., Wong M., Jaffe R.B. Selective estrogen receptor modulators: an update on recent clinical findings. Obstet. Gynecol. Surv. 2008; 63(3): 163-81. https://dx.doi.org/10.1097/OGX.0b013e31816400d7.
  9. Rocha A.L., Oliveira F.R., Azevedo R.C., Silva V.A., Peres T.M., Candido A.L. et al. Recent advances in the understanding and management of polycystic ovary syndrome. F1000Res. 2019; 8: 565. https://dx.doi.org/10.12688/f1000research.15318.1.
  10. Al-Omari W.R., Sulaiman W.R., Al-Hadithi N. Comparison of two aromatase inhibitors in women with clomiphene-resistant polycystic ovary syndrome. Int. J. Gynaecol. Obstet. 2004; 85(3): 289-91. https://dx.doi.org/10.1016/j.ijgo.2003.11.010.
  11. Atay V., Cam C., Muhcu M., Cam M., Karateke A. Comparison of letrozole and clomiphene citrate in women with polycystic ovaries undergoing ovarian stimulation. J. Int. Med. Res. 2006; 34(1): 73-6. https://dx.doi.org/10.1177/147323000603400109.
  12. Lipton A., Demers L.M., Harvey H.A., Kambic K.B., Grossberg H., Brady C. et al. Letrozole (CGS 20267). A phase I study of a new potent oral aromatase inhibitor of breast cancer. Cancer. 1995; 75(8): 2132-8. https://dx.doi.org/10.1002/1097-0142(19950415)75:8<2132::aid-cncr2820750816>3.0.co;2-u.
  13. Sioufi A., Gauducheau N., Pineau V., Marfil F., Jaouen A., Cardot J.M. et al. Absolute bioavailabil- ity of letrozole in healthy post-menopausal women. Biopharm. Drug Dispos. 1997; 18: 779-89. https://dx.doi.org/10.1002/(sici)1099-081x(199712)18:9<779::aid-bdd64>3.0.co;2-5.
  14. Young S.L., Opsahl M.S., Fritz M.A. Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate ther- apy in anovulatory infertile women. Fertil. Steril. 1999; 71(4): 639-44. https://dx.doi.org/10.1016/s0015-0282(98)00537-8.
  15. Amer S.A., Smith J., Mahran A., Fox P., Fakis A. Double-blind randomized controlled trial of letrozole versus clomiphene citrate in subfertile women with polycystic ovarian syndrome. Hum. Reprod. 2017; 32(8): 1631-8. https://dx.doi.org/10.1093/humrep/dex227.
  16. Mejia R.B., Summers K.M., Kresowik J.D., Van Voorhis B.J. A randomized controlled trial of combination letrozole and clomiphene citrate or letrozole alone for ovulation induction in women with polycystic ovary syndrome. Fertil. Steril. 2019; 111(3): 571-8. https://dx.doi.org/10.1016/j.fertnstert.2018.11.030.
  17. Sam S., Ehrmann D.A. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome. Diabetologia. 2017; 60(9): 1656-61. https://dx.doi.org/10.1007/s00125-017-4306-3.
  18. McCartney C.R., Marshall J.C. Clinical practice. Polycystic ovary syndrome. N. Engl. J. Med. 2016; 375(1): 54-64. https://dx.doi.org/10.1056/NEJMcp1514916.
  19. Morgante G., Massaro M.G., Di Sabatino A., Cappelli V., De Leo V. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol. Endocrinol. 2018; 34(1): 4-9. https://dx.doi.org/10.1080/09513590.2017.1370644.
  20. Morley L.C., Tang T., Yasmin E., Norman R.J., Balen A.H. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst. Rev. 2017; (11): CD003053. https://dx.doi.org/10.1002/14651858.CD003053.pub6.
  21. Teede H.J., Misso M.L., Costello M.F., Dokras A., Laven J., Moran L. et al. International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Fertil. Steril. 2018; 110(3): 364-79. https://dx.doi.org/10.1016/j.fertnstert.2018.05.004.
  22. Practice Committee of the American Society for Reproductive Medicine: Role of metformin for ovulation induction in infertile patients with polycystic ovary syndrome (PCOS): a guideline. Fertil. Steril. 2017; 108(3): 426-41. https://dx.doi.org/10.1016/j.fertnstert.2017.06.026.
  23. Sharpe A., Morley L.C., Tang T., Norman R.J., Balen A.H. Metformin for ovulation induction (excluding gonadotrophins) in women with polycystic ovary syndrome. Cochrane Database Syst. Rev. 2019; (12): CD013505. https://dx.doi.org/10.1002/14651858.CD013505.
  24. Costello M.F., Misso M.L., Balen A., Boyle J., Devoto L., Garad R.M. et al. International PCOS Network. Evidence summaries and recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome: assessment and treatment of infertility. Hum. Reprod. Open. 2019; 2019(1). https://dx.doi.org/10.1093/hropen/hoy021.
  25. Garg D., Tal R. Inositol treatment and ART outcomes in women with PCOS. Int. J. Endocrinol. 2016; 2016(1): 1979654. https://dx.doi.org/10.1155/2016/1979654.
  26. Caprio F., D'Eufemia M.D., Trotta K., Campitiello R., Ianniello R., Mele D. et al. Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. J. Ovarian Res. 2015; 8: 37. https://dx.doi.org/10.1186/s13048-015-0167-x.
  27. Papaleo E., Unfer V., Baillargeon J.P., De Santis L., Fusi F., Brigante C. et al. Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Gynecol. Endocrinol. 2007; 23(12): 700-3. https://dx.doi.org/10.1080/09513590701672405.
  28. Minozzi M., Costantino D., Guaraldi C., Unfer V. The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome. Gynecol. Endocrinol. 2011; 27(11): 920-4. https://dx.doi.org/10.3109/09513590.2011.564685.
  29. Ciotta L., Stracquadanio M., Pagano I., Carbonaro A., Palumbo M., Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients: a double blind trial. Eur. Rev. Med. Pharmacol. Sci. 2011;15(5): 509-14.
  30. Morgante G., Massaro M.G., Di Sabatino A., Cappelli V., De Leo V. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol. Endocrinol. 2018; 34(1): 4-9. https://dx.doi.org/10.1080/09513590.2017.1370644.
  31. Agrawal A., Mahey R., Kachhawa G., Khadgawat R., Vanamail P., Kriplani A. Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial. Gynecol. Endocrinol. 2019; 35(6): 511-4. https://dx.doi.org/10.1080/09513590.2018.1549656.
  32. Balen A.H., Conway G.S., Kaltsas G., Techatrasak K., Manning P.J., West C. Polycystic ovary syndrome. InnovAiT. 2016; 9(3): 144-50. https://dx.doi.org/10.1177/1755738015623299.
  33. Назаренко Т.А., Корнеева И.Е., Мишиева Н.Г. Клинические рекомендации. Синдром гиперстимуляции яичников: диагностика, лечение, профилактика, интенсивная терапия. М.: Российское общество акушеров-гинекологов; 2018. [Nazarenko T.A., Korneeva I.E., Mishieva N.G. Clinical recommendations. Ovarian hyperstimulation syndrome: diagnosis, treatment, prevention, intensive care. M.: Russian Society of Obstetricians and Gynecologists; 2018. (in Russian)].
  34. Teede H.J., Misso M.L., Deeks A.A., Moran L.J., Stuckey B.G.A., Wong, J.L.A. et al. Assessment and management of polycystic ovary syndrome: Summary of an evidence-based guideline. Med. J. Aust. 2011; 195(6): S65-112. https://dx.doi.org/10.5694/mja11.10915.
  35. Weiss N.S., Nahuis M.J., Bordewijk E., Oosterhuis J.E., Smeenk J.M.J., Hoek A. et al. Gonadotrophins versus clomifene citrate with or without intrauterine insemination in women with normogonadotropic anovulation and clomifene failure (M-OVIN): a randomized, two-by-two factorial trial. Lancet. 2018; 391(10122): 758-65. https://dx.doi.org/10.1016/S0140-6736(17)33308-1.
  36. Abu Hashim H., Foda O., Ghayaty E. Combined metformin-clomiphene in clomiphene-resistant polycystic ovary syndrome: A systematic review and meta-analysis of randomized controlled trials. Acta Obstet. Gynecol. Scand. 2015; 94(9): 921-30. https://dx.doi.org/10.1111/aogs.12673.
  37. Bordewijk E.M., Nahuis M., Costello M.F., Van der Veen F., Tso L.O., Mol B.W. et al. Metformin during ovulation induction with gonadotrophins followed by timed intercourse or intrauterine insemination for subfertility associated with polycystic ovary syndrome. Cochrane Database Syst. Rev. 2017; (1): CD009090. https://dx.doi.org/10.1002/14651858.CD009090.pub2.
  38. Kalem M.N., Kalem Z., Gurgan T. Effect of metformin and oral contraceptives on polycystic ovary syndrome and IVF cycles. J. Endocrinol. Invest. 2017; 40(7): 745-52. https://dx.doi.org/10.1007/s40618-017-0634-x.
  39. Debras E., Fernandez H., Neveu M-E., Deffieux X., Capmas P. Ovarian drilling in polycystic ovary syndrome: Long term pregnancy rate. Eur. J. Obstet. Gynecol. Reprod. Biology: X. 2019; 4: 100093. https://dx.doi.org/10.1016/j.eurox.2019.100093.
  40. Мартазанова Б.А., Мишиева Н.Г., Абубакиров А.Н. Замена триггера овуляции как метод профилактики развития синдрома гиперстимуляции яичников. Акушерство и гинекология. 2014; 5: 15-8. [Martazanova B.A., Mishieva N.G., Abubakirov A.N. Ovulation trigger replacement as a method for preventing ovarian hyperstimulation syndrome. Obstetrics and Gynecology. 2014; 5: 15-8. (in Russian)].
  41. Мартазанова Б.А., Мишиева Н.Г., Левков Л.А., Грачева А.М., Богатырева Х.А., Ипен С.М., Лапина В.С., Абубакиров А.Н. Оптимизация программ экстракорпорального оплодотворения путем замены триггера овуляции. Акушерство и гинекология. 2015; 10: 73-80. [Martazanova B.A., Mishieva N.G., Levkov L.A., Gracheva A.M., Bogatyreva Kh.A., Eapen S.M., Lapina V.S., Abubakirov A.N. Optimization of in vitro fertilization programs by replacing an ovulation trigger. Obstetrics and Gynecology. 2015; 10: 73-80. (in Russian)].
  42. Qiao J., Feng H.L. Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence. Hum. Reprod. Update. 2011; 17(1): 17-33. https://dx.doi.org/10.1093/humupd/dmq032.
  43. Krishna D., Dhoble S., Praneesh G., Rathore S., Upadhaya A., Rao K. et al. Gonadotropin-releasing hormone agonist trigger is a better alternative than human chorionic gonadotropin in PCOS undergoing IVF cycles for an OHSS Free Clinic: A Randomized control trial. J. Hum. Reprod. Sci. 2016; 9: 164-72. https://dx.doi.org/10.4103/0974-1208.192056.
  44. Wu Y., Tu M., Huang Y., Liu Y., Zhang D. Association of metformin with pregnancy outcomes in women with polycystic ovarian syndrome undergoing in vitro fertilization: a systematic review and meta-analysis. JAMA Netw. Open. 2020; 3(8): e2011995. https://dx.doi.org/10.1093/humupd/dmq032.
  45. Acharya K.S., Acharya C.R., Bishop K., Harris B., Raburn D., Muasher S.J. Freezing of all embryos in in vitro fertilization is beneficial in high responders, but not intermediate and low responders: an analysis of 82,935 cycles from the Society for Assisted Reproductive Technology registry. Fertil. Steril. 2018; 110(5): 880-7. https://dx.doi.org/10.1016/j.fertnstert.2018.05.024.
  46. Колода Ю.А., Подзолкова Н.М., Петриченко Ю.Г. Прогнозирование исходов и выбор оптимальной тактики в программах вспомогательных репродуктивных технологий при синдроме поликистозных яичников. Акушерство и гинекология. 2021; 2: 84-9. [Koloda Yu.A., Podzolkova N.M., Petrichenko Yu.G. Prediction of ART outcomes and treatment of choice in PCOS patients. Obstetrics and Gynecology. 2021; 2: 84-9. (in Russian)]. https://dx.doi.org/10.18565/aig.2021.2.84-89.
  47. Chen Z.J., Shi Y., Sun Y., Zhang B., Liang X., Cao Y. et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome. N. Engl. J. Med. 2016; 375(6): 523-33. https://dx.doi.org/10.1056/NEJMoa1513873.
  48. Deepika K., Suvarna R., Sumi M., Snehal D., Arveen V., Anuja K. et al. HCG trigger versus GnRH agonist trigger in PCOS patients undergoing IVF cycles: frozen embryo transfer outcomes. JBRA Assist. Reprod. 2021; 25(1): 48-58. https://dx.doi.org/10.5935/1518-0557.20200028.
  49. Vuong L.N., Ho V.N.A., Ho T.M., Dang V.Q., Phung T.H., Giang N.H. et al. Effectiveness and safety of in vitro maturation of oocytes versus in vitro fertilisation in women with high antral follicle count: study protocol for a randomised controlled trial. BMJ Open. 2018; 8(12): e023413. https://dx.doi.org/10.1136/bmjopen-2018-023413.
  50. Vuong L.N., Le A.H., Ho V.N.A., Pham T.D., Sanchez F., Romero S. et al. Live births after oocyte in vitro maturation with a prematuration step in women with polycystic ovary syndrome. J. Assist. Reprod. Genet. 2020; 37(2): 347-57. https://dx.doi.org/10.1007/s10815-019-01677-6.

Received 05.03.2021

Accepted 20.04.2021

About the Authors

Nina D. Mikhaylova, graduate student of the 1st Gynecology Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(915)456-81-51. E-mail: mihailnina@mail.ru. 117997, Russia, Moscow, Ac. Oparina str., 4.
Nona G. Mishieva, PhD, Senior Researcher of the 1st Gynecology Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(495)438-26-22. E-mail: nondoc555@mail.ru. 117997, Russia, Moscow, Ac. Oparina str., 4.
Anastasia O. Kirillova, PhD, Senior Researcher of the 1st Gynecology Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel: +7(495)531-44-44. E-mail: a_kozyreva@oparina4.ru. 117997, Russia, Moscow, Ac. Oparina str., 4.
Lana G. Dzhincharadze, graduate student of the 1st Gynecology Department, Academician V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(926)073-77-73. E-mail: lanachka@list.ru. 117997, Russia, Moscow, Ac. Oparina str., 4.

For citation: Mikhailova N.D., Mishieva N.G., Kirillova A.O., Dzhincharadze L.G. Modern methods of infertility treatment in patients with polycystic ovary syndrome.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 7: 37-44 (in Russian)
https://dx.doi.org/10.18565/aig.2021.7.37-44

Similar Articles

№5 / 2024
Dubinskaya E.D., Kolesnikova S.N., Gasparov A.S., Alyoshkina E.V.
Damage-associated molecular patterns in patients with intramural uterine fibroids and infertility
№5 / 2024
Sukhanov A.A., Dikke G.B., Kukarskaya I.I., Pesotskaya А.V.
Morphological characteristics of the endometrium in the preconception period, chorion and placenta during pregnancy resulting from in vitro fertilization in patients with chronic endometritis (secondary analysis of the results of the TULIP 2 randomized controlled trial)
№10 / 2024
Tolibova G.Kh., Tral T.G., Kakhiani M.I.
Possibilities of correction of the endometrial receptor profile in chronic endometritis
№7 / 2024
Ponomareva T.A., Altukhova O.B., Ponomarenko I.V., Churnosov M.I.
Novel concepts in the pathogenesis and risk factors of endometriosis
№10 / 2024
Ivashchenko K.V., Molashenko N.V., Platonova N.M., Roslyakova A.A., Ioutsi V.A., Ovcharov M.V., Antsupova M.A., Lapshina A.M., Buryakina S.A., Beltsevich D.G., Kuznetsov N.S., Andreeva E.N., Troshina E.A., Melnichenko G.A.
Differential diagnosis of hyperandrogenism
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.